
	Dan joined SomaLogic in April 2014 with more than 28 years of financial management experience, including CFO roles at three publicly traded technology growth companies.

	&nbsp;

	At Somalogic, he applies his expertise in finance and operations management, strategic partnering, financing, investor relations, compliance, and mergers and acquisitions to accelerate the company&rsquo;s progress toward commercialization of new products and services and coordinating additional funding for continued growth.

	&nbsp;

	Prior to joining Somalogic, Dan was CFO of bio-industrial company OPX Biotechnologies, where he closed $47 million in equity and debt financing; vice president of finance at bio-pharmaceutical company Pharmion (prior to its acquisition by Celgene); CFO at biotechnology company Repligen Corporation; CFO at medical device manufacturer Physiometrix Inc.; and CFO and chief operating officer at Number Nine Visual Technology, a computer graphics design and manufacturing company.

	&nbsp;

	Dan began his career in public accounting at Ernst &amp; Young.

	&nbsp;

	He earned a B.S. in accounting from the University of Massachusetts &ndash; Amherst and received his CPA certificate in 1990.
